Insider Transactions in Q1 2022 at Predictive Oncology Inc. (POAI)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2022
|
Christina Lee Md Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
6,142
+13.23%
|
-
|
Mar 31
2022
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,530
+11.74%
|
-
|
Mar 31
2022
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,142
+16.83%
|
-
|
Mar 31
2022
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,142
+12.17%
|
-
|
Mar 31
2022
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,530
+9.01%
|
-
|
Mar 31
2022
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,142
+10.44%
|
-
|
Jan 04
2022
|
Christina Lee Md Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
14,709
+30.11%
|
-
|
Jan 04
2022
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,775
+36.06%
|
-
|
Jan 04
2022
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,709
+27.81%
|
-
|
Jan 04
2022
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,709
+24.01%
|
-
|
Jan 04
2022
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,517
+36.17%
|
-
|
Jan 04
2022
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,709
+37.78%
|
-
|
Jan 04
2022
|
J Melville Engle |
BUY
Grant, award, or other acquisition
|
Direct |
20,428
+31.76%
|
-
|